Arthur L Caplan

Dados Biográficos

ID91050
NOMEArthur L Caplan
PRENOMESArthur L
SOBRENOMECaplan
ASSINATURACAPLAN A L
AFILIAÇÕESNew York University
ORCID0000-0002-4061-8011
VERIFICADOSim
TOTAL DE OBRAS94
TOTAL DE CITAÇÕES17
TOTAL COMO AUTOR92
TOTAL COMO EDITOR3
PRIMEIRO ANO DE PUBLICAÇÃO1976
ANO MAIS RECENTE DE PUBLICAÇÃO2026
ÍNDICE H2

  • Leaving no one behind

    Open AccessNancy S Jecker, Tamar Schiff et al.ARTICLEResearch Ethics2026

    If geroscience research delivers on its promise to increase healthy life years, societies around the globe will face profound moral questions. Unlike research addressing diseases such as cardiovascular disease, cancer, or diabetes, biological targeting of the process of senescence has a far wider, almost unprecedented sweep, potentially benefiting all people across the lifespan and future generations. This paper proposes that geroscience products…

  • Public Health Policymaking Outside of the Federal Government

    Lauren A Taylor, Arthur L CaplanARTICLEAmerican Journal of Public Health2026Referências: 3

  • Treating infertility as a missing capability, not a disease

    Michelle J Bayefsky, Arthur L Caplan et al.ARTICLEJournal of Medical Ethics2025

    Infertility patients and patient advocates have long argued for classifying infertility as a disease, in the hopes that this recognition would improve coverage for and access to fertility treatment. However, for many fertility patients, including older women, single women and same-sex couples, infertility does not represent a true disease state. Therefore, while calling infertility a ‘disease’ may seem politically advantageous, it might actually …

  • Why We Can Thrive past Seventy‐Five

    Open AccessCarolyn B Ringel, Michael S Ringel et al.ARTICLEThe Hastings Center Report2025

    About ten years ago, Ezekiel Emanuel wrote an article extolling the benefits of dying at seventy‐five. Since then, longevity and aging interest, research, and funding have exploded. Much of the public is supportive of aging biology research, and books on extending the human lifespan populate bestseller lists. However, the issue remains hotly debated, and many articles published in the lay press spin the research in a negative light. Yet, if we co…

  • Battling measles

    Open AccessF Pasadyn, Felicia L Pasadyn et al.ARTICLEEthics Medicine and Public Health2025

    Measles outbreaks remain a significant global health challenge, particularly in low-resource settings, despite the availability of safe and effective vaccines. The resurgence of measles underscores the critical need to address underlying health inequities that hinder vaccination coverage, such as political instability, growing distrust of all vaccines, economic collapse, and weak healthcare systems. Vulnerable populations, including unvaccinated …

  • Strengthening Research Ethics Capacity in West Africa, 2015–2024

    Open AccessKyle Ferguson, Clement Adebamowo et al.ARTICLEJournal of Empirical Research on…2025Referências: 3

    This article reviews the development and evolution of Fogarty International Center-funded research ethics training programs in West Africa over the past decade. In response to local and global challenges in bioethics and biomedical research, these programs are fostering ethical awareness, shaping local and national ethics review systems, and enhancing bioethics capacity in the region. These efforts have expanded alongside increased democratic gov…

  • Research involving the recently deceased

    Brendan Parent, Olivia S Kates et al.ARTICLEJournal of Medical Ethics2024

    Research involving recently deceased humans that are physiologically maintained following declaration of death by neurologic criteria—or ‘research involving the recently deceased’—can fill a translational research gap while reducing harm to animals and living human subjects. It also creates new challenges for honouring the donor’s legacy, respecting the rights of donor loved ones, resource allocation and public health. As this research model gain…

  • Ethical Challenges of Advances in Vaccine Delivery Technologies

    Open AccessArthur L Caplan, Kyle Ferguson et al.ARTICLEThe Hastings Center Report2024

    Strategies to address misinformation and hesitancy about vaccines, including the fear of needles, and to overcome obstacles to access, such as the refrigeration that some vaccines demand, strongly suggest the need to develop new vaccine delivery technologies. But, given widespread distrust surrounding vaccination, these new technologies must be introduced to the public with the utmost transparency, care, and community involvement. Two emerging te…

  • Why the Gene Was (Mis)Placed at the Center of American Health Policy

    Open AccessKellie Owens, Arthur L CaplanARTICLEThe Hastings Center Report2023

    In Tyranny of the Gene: Personalized Medicine and Its Threat to Public Health (Knopf, 2023), James Tabery traces the ascendance of personalized or precision medicine in America, arguing that America's emphasis on genetics offers more hype than transformational power. In his examination of the power struggles, social relationships, and technological advances that centered the gene in American health policy, Tabery demonstrates how an intensive foc…

  • Regaining Trust in Public Health and Biomedical Science following Covid

    Open AccessArthur L CaplanARTICLEThe Hastings Center Report2023

    Biomedical science suffered a loss of trust during the Covid‐19 pandemic. Why? One reason is a crisis fueled by confusion over the epistemology of science. Attacks on biomedical expertise rest on a mistaken view of what the justification is for crediting scientific information. The ideas that science is characterized by universal agreement and that any evolution or change of beliefs about facts and theories undermines trustworthiness in science a…

  • Priority vaccination for mental illness, developmental or intellectual disability

    Open AccessNina Shevzov-Zebrun, Arthur L CaplanARTICLEJournal of Medical Ethics2022

    Coronavirus vaccines have made their debut. Now, allocation practices have stepped into the spotlight. Following Centers for Disease Control and Prevention guidelines, states and healthcare institutions initially prioritised healthcare personnel and elderly residents of congregant facilities; other groups at elevated risk for severe complications are now becoming eligible through locally administered programmes. The question remains, however: who…

  • Virtual surgical planning and data ownership

    Open AccessWilliam S Konicki, Vivian Wasmuht‐Perroud et al.ARTICLEBioethics2022

    The practice of modern craniomaxillofacial surgery has been defined by emergent technologies allowing for the acquisition, storage, utilization, and transfer of massive amounts of sensitive and identifiable patient data. This alone has thrust providers into an unlikely and unprecedented role as the stewards of vast databases of digital information. This data powers the potent surgical tool of virtual surgical planning, a method by which craniomax…

  • Phantom premise and a shape-shifting ism

    Kyle Ferguson, Arthur L CaplanARTICLEJournal of Medical Ethics2021

    quibble at length with Hassoun's formulation of P1, it runs together two sources of obligation: (1) associative ties that bind community members to one another and (2) role-based obligations of leaders

  • Ethical considerations for protecting the options of subjects in primary epidemic vaccine trials

    Arthur L Caplan, Jerrold L AbrahamARTICLEJournal of Medical Ethics2021

    The recent review by Monrad1 presents several issues about secondary vaccine trials. It lays out the case in which a vaccine has been tested through phases I–III and is being deployed. Subsequently (emphasis added), consideration is being given to conducting ‘trials for another vaccine for the pathogen’. Monrad states: ‘In summary, we may say that researchers have strong prima facie reasons not to conduct a secondary vaccine trial.’ Monrad discus…

  • Love thy neighbour? Allocating vaccines in a world of competing obligations

    Open AccessKyle Ferguson, Arthur L CaplanARTICLEJournal of Medical Ethics2021

    Although a safe, effective, and licensed coronavirus vaccine does not yet exist, there is already controversy over how it ought to be allocated. Justice is clearly at stake, but it is unclear what justice requires in the international distribution of a scarce vaccine during a pandemic. Many are condemning ‘vaccine nationalism’ as an obstacle to equitable global distribution. We argue that limited national partiality in allocating vaccines will be…

  • Knowledge and Attitudes Toward Covid-19 and Vaccines Among a New York Haredi-Orthodox Jewish Community

    Open AccessEllie R Carmody, Devon Zander et al.ARTICLEJournal of Community Health2021

  • Hope to the End

    Open AccessArthur L Caplan, Arthur J Caplan et al.ARTICLEThe Hastings Center Report2021

    In the book Exploiting Hope: How the Promise of New Medical Interventions Sustains Us—and Makes Us Vulnerable, Jeremy Snyder takes on the dominant theory that exploitation in research ethics involves culpable inequity in transactions between parties. He rightly dismisses that economic explanation as inadequate. His theory of exploitation argues that it happens when those who have a duty of beneficence to someone take advantage of their hope. Expl…

  • How Should We Regard Information Gathered in Nazi Experiments

    Open AccessArthur L CaplanARTICLEThe AMA Journal of Ethic2021

    Immorally acquired information from Nazi experimentation or other sources infects the body of scientific and biomedical knowledge. Responding to this reality ethically means insisting on good teaching about the horrific history of such information's sources and careful deliberation about how it is referenced and described

  • Institutional Approaches to Research Integrity in Ghana

    Open AccessAmos Laar, Barbara K Redman et al.ARTICLEScience and Engineering Ethics2020

  • The ethics of the unmentionable

    Arthur L CaplanARTICLEJournal of Medical Ethics2020

    For decades The People’s Republic of China has been expanding its capacity to perform organ transplants, primarily kidneys and livers but also hearts, lungs and multiorgan transplants. The annual number of organ transplants performed is estimated to be over 30 000. The number is expected to grow with a projected market for immunosuppressants expected to be over ¥30 billion/$4.3 billion by 2024.1 China is second only to the USA and is expected to …

  • How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions

    Open AccessCarolyn Riley Chapman, Arthur L CaplanARTICLEThe AMA Journal of Ethic2019

    Hundreds of gene therapies are currently in various stages of research and development. A subset of these involve gene editing technologies such as CRISPR. In this hypothetical case, a patient with chronic pain has initiated a CRISPR-based intervention obtained from a clinic in the Cayman Islands. His physician doubts it is approved by the US Food and Drug Administration and worries about its safety. The case presents ethical questions about pote…

  • Vaccine Trials in Schools

    Alan R Hinman, David G Addi et al.ARTICLEAmerican Journal of Public Health2019Referências: 6

    Vaccine Trials in Schools: We Must Not Ignore Progress Alan R. Hinman MD, MPH, David Addiss MD, MPH, Arthur Caplan PhD, Lisa M. Carlson MPH, James V. Lavery PhD, and Walter A. Orenstein MD Affiliation Alan R. Hinman is with the Center for Vaccine Equity, Task Force for Global Health, Decatur, GA. David Addiss is with the Task Force for Global Health. Arthur Caplan is with the Division of Medical Ethics, New York University School of Medicine, New…

  • Death

    Open AccessArthur L Caplan, Arthur J Caplan et al.ARTICLEThe Hastings Center Report2018

    Constantin Reliu had been working for twenty years as a cook in Turkey when he returned to his hometown of Barlad, Romania, to discover that, there, he was dead. His former wife had, unbeknownst to him, at some point during his stay in Turkey registered him as deceased in Romania. He has since been living a legal nightmare trying to prove to Romanian authorities that he is, in fact, alive. Reliu is not alone in finding out that the legal system i…

  • How Should Clinicians Respond When Patients Are Influenced by Celebrities' Cancer Stories

    Open AccessDivya Yerramilli, Alexandra Charrow et al.ARTICLEThe AMA Journal of Ethic2018

    Despite the prodigious medical literature on cancer care, some patients rely on celebrity narratives as frameworks for understanding their experiences of cancer and as benchmarks for decision making. Regardless of whether these narratives are appropriate sources of health information for patients, it has been shown that celebrity narratives influence patterns of care. Three cases-John McCain, Angelina Jolie, and Jimmy Carter-are presented to illu…

  • The Battle Over Compulsory Vaccination in the United States

    Arthur L CaplanARTICLEAmerican Journal of Public Health2018

    AffiliationsArthur L. Caplan is Head, Division of Medical Ethics, New York University School of Medicine, New York, NY